Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 86337 refers to a laboratory test specifically designed to measure insulin antibody levels in the blood. This test is crucial for assessing the presence of various types of insulin antibodies, which can include human serum autoantibodies that target the body's own insulin, as well as antibodies that may react to exogenous insulin. Exogenous insulin can be derived from different sources, including animal insulin (such as pork or beef), recombinant DNA technology, or insulin analogues. The measurement of these antibodies is particularly significant in the context of diabetes management. It can help identify individuals who are at risk of developing type 1 diabetes mellitus, a condition characterized by the autoimmune destruction of insulin-producing beta cells in the pancreas. Furthermore, this test plays a vital role in differentiating between latent autoimmune diabetes in adults (LADA) and other forms of diabetes, such as type 2 diabetes or gestational diabetes. Additionally, monitoring insulin antibody levels can provide insights into the clinical progression of type 1 diabetes mellitus, aiding healthcare providers in making informed decisions regarding patient care. The test is performed by obtaining a blood sample through a procedure known as venipuncture, which is separately reportable, and the serum is then analyzed using a quantitative radioimmunoassay method.
© Copyright 2026 Coding Ahead. All rights reserved.
The insulin antibodies test (CPT® Code 86337) is indicated for several specific clinical scenarios, including:
The procedure for conducting the insulin antibodies test involves several key steps, which are outlined as follows:
After the insulin antibodies test is completed, there are generally no specific post-procedure care requirements mentioned in the provided data. However, patients may be advised to resume normal activities immediately following the venipuncture. It is important for healthcare providers to communicate the results of the test to the patient and discuss any necessary follow-up actions based on the findings. Monitoring and further evaluation may be warranted depending on the levels of insulin antibodies detected and the clinical context of the patient's health status.
| Short Descr | INSULIN ANTIBODIES | Medium Descr | INSULIN ANTIBODIES | Long Descr | Insulin antibodies | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 235 - Other Laboratory |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | 26 | Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number. | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. | GA | Waiver of liability statement issued as required by payer policy, individual case | GW | Service not related to the hospice patient's terminal condition | GY | Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit | GZ | Item or service expected to be denied as not reasonable and necessary | Q1 | Routine clinical service provided in a clinical research study that is in an approved clinical research study | Q4 | Service for ordering/referring physician qualifies as a service exemption | Q6 | Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area |
|
Date
|
Action
|
Notes
|
|---|---|---|
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.